CAUTION: Investigational Device. Limited by Federal (United States) law to investigational use only.

INDICATION FOR USE: The CESS V1.0 is intended to deliver low-energy electrical stimulation and monitoring for the physiologic evaluation of only VT response to MPT electrotherapy.

CARDIALEN

6160 Summit Drive North, Suite 450

Minneapolis, Minnesota 55430

©2019 Cardialen. All rights reserved.

GENTLY RESTORE NORMAL HEART RHYTHM

We understand that an abnormally fast heart rhythm can have a life-altering impact on a patient and family. For those who are living with atrial fibrillation (AF), ventricular tachycardia (VT) or who have had or are at risk of ventricular fibrillation (VF), Cardialen’s MultiPulse™ Therapy (MPT) is an investigational therapy delivering low-energy pulse therapy to potentially restore a normal heart rhythm. Lower energy could minimize painful and potentially damaging side effects associated with current therapies.

DETECT

AND TREAT AF

Learn more >

REDUCE

HIGH-ENERGY SHOCKS

Learn more >

TARGET

MULTIPLE ARRHYTHMIAS USING LOW ENERGY

Learn more >

HOW MULTIPULSE THERAPY WORKS

How MultiPulse Therapy can potentially detect and treat atrial fibrillation (AF), rapid ventricular tachycardia (VT) and ventricular fibrillation (VF).

home.png

FIND OUT MORE  Explore the latest innovation in tachyarrhythmia technology.

 

ABOUT US

Advancing cardioversion and defibrillation using low-energy therapy

Cardialen, Inc. is an early-stage medical device company dedicated to advancing implantable cardioversion and defibrillation using low energy for use as a first-line therapy to restore normal heart rhythm and may reduce the potential for high-energy defibrillation shocks.

 

Our MultiPulse Therapy (MPT) is currently being studied in an FDA-approved early feasibility IDE clinical trial exploring how a sequence of low-energy pulses timed to stop abnormal heart rhythms may restore normal heart rhythm using less energy than current high-energy shocks.

 

CAUTION: Investigational Device. Limited by Federal (United States) law to investigational use only 

 
LEARN MORE ABOUT CLINICAL TRIALS
If you are a patient or physician interested in learning more about clinical trials, please contact us.

Cardialen, Inc.

6160 Summit Drive North, Suite 450

Minneapolis, Minnesota 55430

612.208.1260

Get directions

Email us: info@cardialen.com

Media contact

Michael Walsh

612.718.8952

MichaelWalshCommunications.com

EMPLOYMENT INQUIRIES

Interested in joining the Cardialen team?

Please complete the form.